Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 96.97 (-0.16), GD: 141.54 (+0.23), LMT: 196.43 (+0.66), HON: 101.96 (-0.02), RTN: 110.47 (+0.29), NOC: 151.76 (+0.44), KMB: 117.77 (-0.21), XOM: 93.78 (-0.81), IBB: 299.80 (+5.12), VSAT: 63.75 (-0.20), NVGS: 20.00 (+2.10), JACK: 78.82 (-0.17), RIG: 18.77 (-0.37), Q: 59.48 (+0.01), COST: 143.65 (-0.50), WAG: 76.67 (+0.16), ETN: 69.30 (-0.09), MDSO: 47.27 (+0.15), DIS: 94.42 (-0.27), WFC: 55.34 (-0.13), PLKI: 55.50 (+0.01), BA: 131.24 (+1.21), DENN: 9.96 (+0.05), CBRL: 138.16 (+0.46), GILD: 91.29 (+1.84), CVX: 113.47 (-0.48)
Jim Cramer's Top Stock Picks: BA MMM ISIS Q
at The Street - Fri Dec 19, 5:00AM CST
Cramer says Isis Pharmaceuticals is the next hot biotech and he's a big fan of drug testing provider Quintiles.
MMM: 166.96 (+0.09), Q: 59.48 (+0.01), ISIS: 59.49 (+1.88), BA: 131.24 (+1.21)
Cramer's Mad Money - Which Biotech Is The Next Regeneron? (12/18/14)
SA Editor Miriam Metzinger - Seeking Alpha - Fri Dec 19, 4:45AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday December 18. Recipe For a Rally: Rite Aid (NYSE: RAD ), Kraft (NASDAQ: KRFT ), Accenture (NYSE: ACN ), Darden (NYSE: DRI ), Boeing (NYSE: BA ), 3M (NYSE:...
MMM: 166.96 (+0.09), ISIS: 59.49 (+1.88), Q: 59.48 (+0.01), JBL: 21.88 (+0.17), WYNN: 150.90 (-0.79), KRFT: 63.90 (-0.11), MGM: 20.77 (-0.17), BA: 131.24 (+1.21), ACN: 91.32 (-0.10), REGN: 400.12 (+6.07), DRI: 58.42 (-0.09), RAD: 7.26 (-0.09)
Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally
at The Street - Thu Dec 18, 7:10PM CST
Cramer lists 10 ingredients in this seasonally strong market that will lead to a rally.
WFM: 48.67 (-0.40), MMM: 166.96 (+0.09), WMT: 86.43 (-0.23), HSBC: 47.71 (+0.18), M: 64.26 (+0.22), BA: 131.24 (+1.21), CELG: 109.60 (+3.48), SBUX: 81.27 (-0.16), RIG: 18.77 (-0.37), ISIS: 59.49 (+1.88), JPM: 62.48 (unch), Q: 59.48 (+0.01), GILD: 91.29 (+1.84), KBR: 17.00 (-0.13), FLR: 60.30 (-0.26), COST: 143.65 (-0.50), REGN: 400.12 (+6.07)
Quintiles CEO Tom Pike to Present at J.P. Morgan Healthcare Conference
Business Wire - Wed Dec 17, 7:00AM CST
Quintiles CEO Tom Pike will present at the 2015 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 in San Francisco at the Westin St. Francis Hotel.
Q: 59.48 (+0.01), JPM: 62.48 (unch)
Cancer Genetics (CGIX) Looks Good: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:25AM CST
Cancer Genetics (CGIX) was a big mover last session, with shares rising just over 8% on the day.
Q: 59.48 (+0.01), CRL: 63.59 (+0.33), ICLR: 52.66 (+0.72), CGIX: 7.12 (+0.06)
Quintiles Named 2014 Frost & Sullivan Asia-Pacific CRO of the Year
Business Wire - Mon Dec 08, 10:15PM CST
For the sixth time in eight years, Quintiles has been named Asia-Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and consulting firm. The award honors the CRO that scores the highest in Frost & Sullivan's evaluation of several performance categories, including customer service; price/performance value; pioneering best practices; and addressing unmet needs.
Q: 59.48 (+0.01)
Life Sciences Tools and Services Equities Coverage - Agilent Technologies, Thermo Fisher Scientific, Bruker, Quintiles Transnational, and Covance
PR Newswire - Mon Dec 08, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Bruker Corporation (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), and Covance Inc. (NYSE: CVD). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 05, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,958.79, up 0.33% and the NASDAQ Composite closed at 4,780.76, up 0.24%. The S&P 500 finished the session 0.17% higher at 2,075.37. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index advancing 10.21% in the previous three months. Register for your complimentary reports on these five stocks at:
Q: 59.48 (+0.01), TMO: 126.79 (+0.13), A: 41.13 (-0.24), BRKR: 19.50 (+0.09), CVD: 103.73 (+0.02)
This Stock May Be Boring, but That’s What Makes It Great
Motley Fool Staff - Motley Fool - Fri Dec 05, 7:15AM CST
Sometimes the most "boring" stocks can actually make pretty exciting long-term investments. Here are three of our analysts' favorites that can help you build wealth in your portfolio. Patrick Morris: An investment in Realty Income may not...
Q: 59.48 (+0.01), DG: 69.86 (+0.31), CB: 104.37 (-0.07), O: 49.42 (+0.33), WAG: 76.67 (+0.16)
Quintiles Named Best Contract Research Organization at SCRIP Awards for Third Consecutive Year
Business Wire - Thu Dec 04, 7:00AM CST
Quintiles today announced that the company was awarded "Best Contract Research Organization" at the annual SCRIP Awards for the third year in-a-row. This is the company's fourth award received in this category in the last five years. The SCRIP Awards acknowledge excellence in the biopharmaceutical industry, based on judging by an independent panel of 12 life sciences experts.
Q: 59.48 (+0.01)
Quintiles Launches Marketed Product Maintenance Offering to Better Manage Established Products
Business Wire - Mon Dec 01, 7:11AM CST
Quintiles today announced a new offering that combines its industry-leading pharmacovigilance, regulatory dossier/label maintenance, benefit-risk management, and analytic expertise into one integrated solution. This solution will help biopharmaceutical companies better manage all activities required to maintain the licenses for their portfolio of marketed products.
Q: 59.48 (+0.01)
'Mad Money' Lightning Round: I Think Twitter Needs a New CEO
at The Street - Tue Nov 25, 5:00AM CST
Cramer wants you to stay out of Cliffs Natural and likes Kinder Morgan over Cenovus Energy.
KMI: 42.01 (+0.10), IMS: 26.30 (-0.03), MCK: 209.79 (+0.58), Q: 59.48 (+0.01), GILD: 91.29 (+1.84), CLF: 6.06 (-0.09), THG: 71.98 (+0.36), TWTR: 37.61 (+0.04), CVE: 20.70 (-0.25)
Cramer's Lightning Round - Twitter CEO Dick Costolo Should Spend More Time With His Family (11/24/14)
SA Editor Miriam Metzinger - Seeking Alpha - Tue Nov 25, 4:55AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday November 24. Bullish Calls: Quintiles (NYSE: Q ), McKesson (NYSE: MCK ): Cramer prefers these stocks to IMS Health. Cliffs Natural Resources...
KMI: 42.01 (+0.10), IMS: 26.30 (-0.03), MCK: 209.79 (+0.58), Q: 59.48 (+0.01), VALE: 8.09 (-0.05), CLF: 6.06 (-0.09), THG: 71.98 (+0.36), CVE: 20.70 (-0.25), TWTR: 37.61 (+0.04)
Jim Cramer's 'Mad Money' Recap: Here's Where Money Managers Should Put Their Money
at The Street - Mon Nov 24, 7:22PM CST
Money managers need investing ideas and Cramer has a boatload for them.
KO: 42.94 (-0.03), MCK: 209.79 (+0.58), SWKS: 74.32 (+0.92), CAH: 82.07 (+0.15), GB: 49.34 (-0.36), BAC: 17.98 (+0.05), CLF: 6.06 (-0.09), THG: 71.98 (+0.36), WDC: 113.11 (-0.18), CVE: 20.70 (-0.25), PEP: 97.09 (-0.27), CELG: 109.60 (+3.48), ZTS: 43.84 (+0.87), YHOO: 50.65 (+0.63), IMS: 26.30 (-0.03), LB: 85.06 (unch), Q: 59.48 (+0.01), GILD: 91.29 (+1.84), GOOGL: 536.93 (-1.84), TWTR: 37.61 (+0.04), AAPL: 112.01 (-0.53), DOW: 46.01 (+0.03), SNDK: 100.65 (+0.27), REGN: 400.12 (+6.07), CSCO: 28.30 (+0.05)
Quintiles Named a Best Workplace in South Korea
Business Wire - Tue Nov 18, 10:00PM CST
Quintiles announced today that it has been recognized as one of South Korea's Best Workplaces by the Great Place to Work(R) Institute. This is Quintiles Korea's first time to receive the award; it joins many other Quintiles' offices worldwide similarly honoured by the Great Place to Work Institute.
Q: 59.48 (+0.01)
Covance (CVD) Sellout Decision to LabCorp: A Strategic Fit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 3:10PM CST
On Nov 18, we issued an updated research report on Covance Inc. (CVD).
Q: 59.48 (+0.01), LH: 107.69 (+0.56), SNY: 46.35 (+0.50), CVD: 103.73 (+0.02)
InsiderInsights.com Daily Round Up 11/12/14: DVA, PSEC, MRC, SUMR
InsiderInsights - at Seeking Alpha - Fri Nov 14, 3:44PM CST
HAS: 55.25 (+0.03), CJES: 13.39 (-0.29), FB: 80.77 (+0.16), MRC: 15.52 (-0.41), SUMR: 3.10 (+0.06), MYL: 56.97 (+0.39), GOOG: 528.77 (-1.82), GSAT: 2.97 (+0.03), CHRS: 14.85 (+0.79), GGP: 28.34 (-0.09), DVA: 76.06 (+0.07), Q: 59.48 (+0.01), SPW: 86.64 (-0.11), RCPT: 122.05 (+4.05), DATA: 88.76 (+0.04), X: 26.51 (+0.11), PSEC: 8.59 (-0.02), SCHW: 30.67 (+0.01), ERII: 5.06 (-0.03)
InsiderInsights.com Daily Round Up 11/13/14: TWX, NMFC, NES, MEMP
InsiderInsights - at Seeking Alpha - Thu Nov 13, 11:45PM CST
NMFC: 14.85 (-0.06), NES: 4.96 (-0.44), JIVE: 6.08 (unch), SMG: 62.46 (-0.11), SUMR: 3.10 (+0.06), WFC: 55.34 (-0.13), GOOG: 528.77 (-1.82), DISH: 72.63 (+0.54), TWX: 85.58 (-0.20), NVRO: 37.95 (-0.93), TTS: 8.87 (+0.04), MEMP: 14.46 (-0.31), VSAR: 22.25 (-0.11), V: 267.63 (+2.37), NOW: 69.69 (+0.12), Q: 59.48 (+0.01), OPK: 9.63 (+0.21), DATA: 88.76 (+0.04), AN: 59.74 (+0.33)
An Injection Of Caution Ahead Of PRA Health Sciences' IPO
Don Dion - at Seeking Alpha - Thu Nov 13, 8:34AM CST
CG: 26.90 (-0.39), Q: 59.48 (+0.01), CTLT: 27.38 (+0.23), PRAH: 25.12 (-0.38), KKR: 23.14 (+0.24)
Should You Get Rid of Air Methods (AIRM) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:42AM CST
Air Methods has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off
AIRM: 43.03 (-0.10), Q: 59.48 (+0.01), BEAT: 10.15 (+0.09), ICLR: 52.66 (+0.72)